Pulmonary cryptococcosis in HIV infection;CRYPTOCOCCOSE PULMONAIRE AU COURS DE L'INFECTION A VIH

Revue des Maladies Respiratoires

Volumn 14, Issue 5, 1997, Pages 365-370

  Balloul, E ^a   Couderc, L J ^a   Molina, J M ^b   Cahite, I ^c   Wolff, M ^c   Saimot, A G ^c   Caubarrere I ^a  

^a FOCH HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

AIDS; Amphotericin B; Cryptococcosis; Fluconazole

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CEREBROSPINAL FLUID CULTURE; CLINICAL ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CULTURAL ANTHROPOLOGY; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG INFECTION; LUNG LAVAGE; MALE; PATIENT; PLEURA EFFUSION; PNEUMOCYSTIS CARINII; THORAX RADIOGRAPHY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; FLUCONAZOLE; HIV INFECTIONS; HUMANS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES;

EID: 0030772940     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. CHUCK LS, SANDE MA : Infection with Cryptococcus neoformans in the Acquired Immunodeficiency Syndrome. N Engl J Med 1981;321:794-9.
2. Centre National de référence des mycoses et des antifongiques. Enquête épidémiologique concernant la cryptococcose en France métropolitaine. Bulletin Epidémiologique hebdomadaire. 1992;16:70-1.
3. BISSAGNENE E, OUHON J, KRA O, KAMIO A : Aspects actuels de la cryptococcose neuroméningée à Abidjan. Med Infect 1994;24:580-5.
4. ELLIS DH, PFEIFFER TJ : Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 1990;336:923-5.
5. WASSER L, TALAVERA W : Pulmonary cryptococcosis in AIDS. Chest 1987;92:692-5.
6. MILLER WT, EDELMAN JM, MILLER WT : Cryptococcal pulmonary infection in patients with AIDS : radiographic appearance. Radiology 1990;175:725-8.
7. CLARK RA, GREER DL, VALAINIS GT, HYSLOP NE : Cryptococcus neoformans pulmonary infection in HIV-1 infected patients. J Acquir Immune Defic Syndr 1990;3: 480-4.
8. CAMERON ML, BARTLETT JA, GALLIS HA, WASKIN HA : Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis 1991;13:64-7.
9. BATUNGWANAYO J, TAELMAN H, BOGAERTS J et al. : Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda : a retrospective study of 37 cases. AIDS 1994;5:1271-6.
10. MEYOHAS MC, Roux P, BOLLENS D et al. : Pulmonary cryptococcosis : localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis 1995;21:628-33.
11. DE TRUCHIS P, CADRANEL J, TOUBOUL JL et al. : Fréquence respective et aspects immunologiques de 150 pneumopathies observées chez 125 malades infectés par le virus de l'immunodéficience humaine. Presse Med 1988;17:781-5.
12. KHOURY MB, GODWIN JD, GALLIS HA, HALVORSEN RA, PUTMAN CE : Thoracic cryptococcosis : immunologic competence and radiologic appearance. AJR 1984;141:893-6.
13. SAIMOT AG, GIRARD PM : Pneumopathie à Pneumocystis carinii au cours de l'infection VIH. Presse Med 1991; 20:258-64.
14. MALABONGA VM, BASTI J, KAMHOLZ SL : Utility of bronchoscopic sampling techniques for cryptococcal disease in AIDS. Chest 1991;99:370-2.
15. CHECHANI V, KAMHOLZ SL : Pulmonary manifestation of disseminated cryptococcosis in patients with AIDS. Chest 1990;98;1060-6.
16. American thoracic society. Fungal infection in HIV-infected persons. Am J Respir Crit Care Med 1995;152:816-22.
17. BAUGHMAN RP, RHODES JC, DOHN MN, HENDERSON H, FRAME PT : Detection of cryptococcal antigen in bronchoalveolar lavage fluid : a prospective study of diagnostic utility. Am Rev Respir Dis 1992;145:1226-9.
18. MURRAY JF, MILLS J : State of the Art. Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis 1990;141:1582-98.
19. MOORE RD, CHAISSON RE : Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996;124:633-42.
20. LUCHON L, COUDERC LJ, STERN M, FRIARD S, CAUBARRÈRE I : Pneumocytoses pulmonaires révélant l'infection VIH. Presse Med 1994;20:951.
21. KERKERING TM, DUMA RJ, SHADOMY S : The evolution of pulmonary cryptococcosis. Clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981;94:611-6.
22. MASUR H, SHELHAMER J : Empiric outpatient management of HIV-related pneumonia : economical or unwise ? Ann Intern Med 1996;124:451-3.
23. LARSEN RA, LEAL MA, CHAN LS : Fluconazole compared with Amphotericin B plus Flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990;113:183-7.
24. SAAG MS, POWDERLY WG, CLOUD GA et al : Comparison of Amphotericin B with Fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9.
25. HAUBRICH RH, HAGHIGHAT D, BOZZETTE SA, TILLES J, MC CUTCHAN JA and the California collaborative treatment Group. High-dose Fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. J Infect Dis 1994;170:238-42.
26. DENNING DW, TUCKER RM, HANSON LH, HAMILTON JR, STEVENS DA : Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989;149:2301-8.
27. DE GANS J, PORTEGIES P, TIESSENS G et al. : Itraconazole compared with Amphotericin B plus Flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992;6:185-90.
28. MITCHELL TG, PERFECT JR : Cryptococcosis in the era of AIDS - 100 years after the discovery of cryptococcus neoformans. Clin Microb Rev 1995;8:515-48.
29. BOZZETTE SA, LARSEN RA, CHIU J et al. : A placebocontrolled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the Acquired Immunodeficiency Syndrome. N Engl J Med 1991;324:580-4.
30. POWDERLY WG, SAAG MS, CLOUD GA et al. : A controlled trial of Fluconazole or Amphotericin B to prevent relapse of cryptococcal meningitis in patient with the Acquired Immunodeficiency Syndrome. N Engl J Med 1992;326:793-5.
31. NELSON MR, FISHER M, CARTLEDGE J, ROGERS T. GAZZARD BG : The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS 1994;8:651-4.
32. PINNER RW, HAJJEH RA, POWDERLY WG : Prospect for preventing cryptococcosis in persons infected with Human Immunodeficiency Virus. Clin Infect Dis 1995;21(suppl 1): S103-7.
33. DROMER F, MATHOULIN S, DUPONT B, LAPORTE A et le Groupe d'étude de la cryptococcose en France. La surveillance de la cryptococcose en France métropolitaine. Bulletin Epidémiologique Hebdomadaire. 1995; 49:213-4.
34. CAMERON ML, GRANGER DL, MATTHEWS TJ, BRICE WEINBERG J : Human Immunodeficiency Virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J Infect Dis 1994;170:60-7.
35. HARRISON TS, KORNFELD H, LEVITZ SM : The effect of infection with Human Immunodeficiency Virus on the anticryptococcal activity of lymphocytes and monocytes. J Infect Dis 1995;172:665-71.
36. PETTOELLO MANTOVANI M, CASADEVALL A, KOLLMANN T, RUBINSTEIN A, GOLDSTEIN H : Enhancement of HIV 1 infection by the capsular polysaccharide of cryptococcus neoformans. Lancet 1992;329:21-3.